RxDoctor Payments Data

David Forcione, MD

Gastroenterology · Boston, MANPI 1093796914

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (42.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 77.2% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2023 at $26,289 and has fallen 58.3% since, to $10,960 in 2025. Among gastroenterology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$49,264in general payments, 2019–2025

Across 225 payments — averaging $218.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$38K
  • Conmed Corporation$3K
  • Pentax Of America, Inc.$2K
  • Cook Medical LLC$1K
  • Medtronic$891
  • Endogastric Solutions, Inc$604
  • plus $4K from 23 others

What the payments were for

  • Consulting fees$12,00024%
  • Speaking & faculty fees$21,12543%
  • Grants$290%
  • Travel & lodging$2,1214%
  • Food & beverage$13,99028%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,264 in reported general payments places this provider in the 90th percentile of 579 gastroenterology providers in Massachusetts.

See all gastroenterology providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$515,206
Medicare patients
803
Services billed
2,701

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levofloxacin97$292
Pantoprazole Sodium11$173
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav22$97

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →